There should be some buying in the next two weeks in conjuction with the split. The company will most likely do the buying--part of the share buy back plan to boost the price prior to the split. we might see 75-78 range again. I seriously doubt it will go up to 80. Watch it out.
I agree with you on the price range. I think the creeping is underway. I also believe by the 28th it will hit 78-79 area. Now the Post Price should be 40-42. My reasoning is they did increase the div. Also when an issue goes When Issue(WI) it usually trades a half to one & one half points higher. This seems to be the case of most of the stocks splits that I've been part of.
I know there are complants about the pipeline of new products. ABT web site is not a good one for investor information. I wonder if investors online complain via their E-Mail at the site. Intel's site is an excellent site for information. Just a thought.
I also agree with the analysis. The reason given by cli2 is sound. I used to work at Abbott, although the pipeline in pharmaceutical area is weak, its diagnostic division is fairly strong and is picking up stength and it will carry Abbott for the next few quarters. I actually think Abbott will be doing slightly better than most analysts predicted. The management changes are definitely good for Abbott, and will carry it to the 21st century. Look for a number of potential acquisitions Abbott will engage in the next several months, including top biotech companies, generic drug companies (!!!!) and genomic firms. At least we will see one such merger or buyout this year--it is an easy prediction because that is what Abbott has to do and must do. Potential targets are Eli Lilly, Pathogenesis, Andrex, Curagen and Aurora Bioscience, etc. Got to go, good luck and be patient.